You are here

Home

Biblio

Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, Tosto G, White C, Terzikhan N, Cruchaga C et al..  2021.  Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.. Alzheimers Dement. 17(10):1663-1674.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Tan CHong, Bonham LW, Fan CChieh, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL et al..  2019.  Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.. Brain. 142(2):460-470.
Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J, Hardy J, Escott-Price V.  2019.  Polygenic risk and hazard scores for Alzheimer's disease prediction.. Ann Clin Transl Neurol. 6(3):456-465.
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA et al..  2021.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.. Ann Neurol. 90(3):366-376.
Wu J, Dong Q, Gui J, Zhang J, Su Y, Chen K, Thompson PM, Caselli RJ, Reiman EM, Ye J et al..  2021.  Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases.. Front Neurosci. 15:669595.
Liu Y, Wang M, Marcora EM, Zhang B, Goate AM.  2019.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.. Neurosci Lett. 711:134403.
Choi KYeong, Lee JJae, Gunasekaran TIniyan, Kang S, Lee W, Jeong J, Lim HJae, Zhang X, Zhu C, Won S-Y et al..  2019.  Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of ε4 on Alzheimer's Disease Risk in a Multiracial Sample.. J Clin Med. 8(8)
Sun D, Tiedt S, Yu B, Jian X, Gottesman RF, Mosley TH, Boerwinkle E, Dichgans M, Fornage M.  2019.  A prospective study of serum metabolites and risk of ischemic stroke.. Neurology. 92(16):e1890-e1898.
Ramos-Miguel A, Jones AA, Petyuk VA, Barakauskas VE, Barr AM, Leurgans SE, De Jager PL, Casaletto KB, Schneider JA, Bennett DA et al..  2021.  Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample.. Acta Neuropathol. 141(5):755-770.
Tang Z-Z, Sliwoski GR, Chen G, Jin B, Bush WS, Li B, Capra JA.  2020.  PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection.. Genome Biol. 21(1):217.
Feliciano-Astacio BE, Celis K, Ramos J, Rajabli F, Adams LDeon, Rodriguez A, Rodriguez V, Bussies PL, Sierra C, Manrique P et al..  2019.  The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach.. Front Genet. 10:538.
Q
Naj AC, Lin H, Vardarajan BN, White S, Lancour D, Ma Y, Schmidt M, Sun F, Butkiewicz M, Bush WS et al..  2018.  Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project.. Genomics.
Zhao L, Zhang Z, Rodriguez SMBarral, Vardarajan BN, Renton AE, Goate AM, Mayeux R, Wang GT, Leal SM.  2020.  A quantitative trait rare variant nonparametric linkage method with application to age-at-onset of Alzheimer's disease.. Eur J Hum Genet. 28(12):1734-1742.
R
Beecham GW, Vardarajan B, Blue E, Bush W, Jaworski J, Barral S, DeStefano A, Hamilton-Nelson K, Kunkle B, Martin ER et al..  2018.  Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease.. Neurol Genet. 4(6):e286.
Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, Glaab E, Bobbili DReddy, Antony P, Koegelsberger S et al..  2020.  A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.. Mol Psychiatry. 25(3):629-639.
Zhang X, Zhu C, Beecham G, Vardarajan BN, Ma Y, Lancour D, Farrell JJ, Chung J, Mayeux R, Haines JL et al..  2019.  A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.. Alzheimers Dement. 15(3):441-452.
Sariya S, Lee JH, Mayeux R, Vardarajan BN, Reyes-Dumeyer D, Manly JJ, Brickman AM, Lantigua R, Medrano M, Jimenez-Velazquez IZ et al..  2019.  Rare Variants Imputation in Admixed Populations: Comparison Across Reference Panels and Bioinformatics Tools.. Front Genet. 10:239.
Zhan L, Li J, Jew B, Sul JHoon.  2021.  Rare variants in the endocytic pathway are associated with Alzheimer's disease, its related phenotypes, and functional consequences.. PLoS Genet. 17(9):e1009772.
González HM, Tarraf W, Fornage M, González KA, Chai A, Youngblood M, Abreu Mde Los Ang, Zeng D, Thomas S, Talavera GA et al..  2019.  A research framework for cognitive aging and Alzheimer's disease among diverse US Latinos: Design and implementation of the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).. Alzheimers Dement. 15(12):1624-1632.
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, Marcora E, Huang K-L, Porter T, Laws SM et al..  2020.  Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture.. Nat Commun. 11(1):4799.
Gardner OK, Wang L, Van Booven D, Whitehead PL, Hamilton-Nelson KL, Adams LD, Starks TD, Hofmann NK, Vance JM, Cuccaro ML et al..  2019.  RNA editing alterations in a multi-ethnic Alzheimer disease cohort converge on immune and endocytic molecular pathways.. Hum Mol Genet. 28(18):3053-3061.
S
Knopman D, Lemere CA, Lamb BT, Craft S, Gitlin LN, Golde TE, Pericak-Vance M, Sano M, Schellenberg G, Schneider JA et al..  2020.  Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community.. Alzheimers Dement. 16(7):1095-1098.
Spartano NL, Davis-Plourde KL, Himali JJ, Murabito JM, Vasan RS, Beiser AS, Seshadri S.  2019.  Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study.. J Diabetes Res. 2019:2718465.
Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K, Markus HS.  2019.  Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study.. Neurology. 92(9):e944-e950.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer